Erasca, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Erasca, Inc. on November 19, 2021. The filing discloses the entry into a material definitive agreement regarding the Company's corporate headquarters lease.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a lease amendment.
Material Changes
- Lease Expiration: The expiration date of the lease for the Company's headquarters at 10835 Road to the Cure, Suite 140, San Diego, CA, was amended from May 31, 2024, to April 1, 2022.
- Relocation: The amendment facilitates the Company's planned relocation to new premises at 3115 Merryfield Row, Third Floor, San Diego, CA 92121.
- Costs: No additional fees are payable in connection with the execution of the amendment or the early expiration of the lease.
Outlook and Management Commentary
Management indicates the lease change is directly tied to the planned relocation of corporate headquarters. The full text of the Second Amendment to Lease is expected to be filed as an exhibit to the Company's Annual Report on Form 10-K for the year ended December 31, 2021.
Investor Verification Checklist
- Verify the terms and costs of the new lease agreement at 3115 Merryfield Row.
- Confirm the timeline for the physical relocation of operations.
- Review the upcoming Form 10-K for the full text of the Second Lease Amendment.